<!DOCTYPE html>
<html lang="en-uk">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 2.4.0">
  <meta name="generator" content="Hugo 0.49" />
  <meta name="author" content="Githinga, Benson">

  
  
  
  
    
  
  <meta name="description" content="Background: Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding of the mechanism of natural immunity. We report consensus population level impact projections based on two mathematical models applied to a low income setting. Method: Two structurally distinct age-specific deterministic compartmental models reflecting uncertainty associated with the natural history of infection and the mechanism by which immunity is acquired and lost were constructed. A wide range of vaccine TPPs were explored including dosing regime and uptake, and effects in the vaccinated individual on infectiousness, susceptibility, duration of protection, disease severity and interaction with maternal antibodies and natural induced immunity. These were combined with a range of vaccine implementation strategies, targeting the highest priority age group and calibrated using hospitalization data from Kilifi County Hospital, Kenya. Findings: Both models were able to reproduce the data. The impact predicted by the two models was qualitatively similar across the range of TPPs, although one model consistently predicted higher impact than the other. For a proposed realistic range of scenarios of TPP combinations, the models predicted up to 70% reduction in hospitalizations in children under five years old. Vaccine designs which reduced the duration and infectiousness of infection were predicted to have higher impacts. The models were sensitive to the coverage and rate of loss of vaccine protection but not to the interaction between vaccine and maternal/naturally acquired immunity. Conclusion: The results suggest that vaccine properties leading to reduced virus circulation by lessening the duration and infectiousness of infection upon challenge are of major importance in population RSV disease control. These features should be a focus for vaccine development.">

  
  <link rel="alternate" hreflang="en-uk" href="/publication/rsv_gsk_kilifi/">

  


  

  

  

  
  
  
  <meta name="theme-color" content="#0095eb">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha256-eSi1q2PG6J7g7ib17yAaWMcrr5GrtohYChqibrV7PBE=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.3.1/css/all.css" integrity="sha384-mzrmE5qonljUremFsqc01SB46JvROS7bZs3IO2EmfFsd15uHvIt+Y8vEf7N7fWAU" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css" crossorigin="anonymous">
        
      
    

    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.css" integrity="sha512-M2wvCLH6DSRazYeZRIm1JnYyh22purTM+FDB5CsyxtQJYeKq83arPe5wgbNmcFXGqiSH2XR8dT/fJISVA1r/zQ==" crossorigin="anonymous">
    

    

  

  
  
  <link rel="stylesheet" href=//fonts.googleapis.com/css?family=Montserrat:400,700|Roboto:400,400italic,700|Roboto+Mono>
  

  <link rel="stylesheet" href="/styles.css">
  

  
  
  

  
  <link rel="alternate" href="/index.xml" type="application/rss+xml" title="Benson Githinga">
  <link rel="feed" href="/index.xml" type="application/rss+xml" title="Benson Githinga">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/publication/rsv_gsk_kilifi/">

  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="Benson Githinga">
  <meta property="og:url" content="/publication/rsv_gsk_kilifi/">
  <meta property="og:title" content="Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach | Benson Githinga">
  <meta property="og:description" content="Background: Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding of the mechanism of natural immunity. We report consensus population level impact projections based on two mathematical models applied to a low income setting. Method: Two structurally distinct age-specific deterministic compartmental models reflecting uncertainty associated with the natural history of infection and the mechanism by which immunity is acquired and lost were constructed. A wide range of vaccine TPPs were explored including dosing regime and uptake, and effects in the vaccinated individual on infectiousness, susceptibility, duration of protection, disease severity and interaction with maternal antibodies and natural induced immunity. These were combined with a range of vaccine implementation strategies, targeting the highest priority age group and calibrated using hospitalization data from Kilifi County Hospital, Kenya. Findings: Both models were able to reproduce the data. The impact predicted by the two models was qualitatively similar across the range of TPPs, although one model consistently predicted higher impact than the other. For a proposed realistic range of scenarios of TPP combinations, the models predicted up to 70% reduction in hospitalizations in children under five years old. Vaccine designs which reduced the duration and infectiousness of infection were predicted to have higher impacts. The models were sensitive to the coverage and rate of loss of vaccine protection but not to the interaction between vaccine and maternal/naturally acquired immunity. Conclusion: The results suggest that vaccine properties leading to reduced virus circulation by lessening the duration and infectiousness of infection upon challenge are of major importance in population RSV disease control. These features should be a focus for vaccine development.">
  
  
    
  <meta property="og:image" content="/img/icon-192.png">
  <meta property="og:locale" content="en-uk">
  
  <meta property="article:published_time" content="2017-01-05T13:26:31&#43;01:00">
  
  <meta property="article:modified_time" content="2017-01-05T13:26:31&#43;01:00">
  

  

  

  <title>Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach | Benson Githinga</title>

</head>
<body id="top" data-spy="scroll" data-target="#TableOfContents" data-offset="71" >

<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">Benson Githinga</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#about">
            
            <span>Home</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#skills">
            
            <span>Skills</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#experience">
            
            <span>Experience</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#contact">
            
            <span>Contact</span>
            
          </a>
        </li>

        
        

      

        

        
      </ul>

    </div>
  </div>
</nav>

<div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  





  <div class="article-container">
    <h1 itemprop="name">Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach</h1>
    <span class="pub-authors" itemprop="author">
      
      Pan-Ngum W, Kinyanjui TM, Kiti M, Taylor S, Toussaint J, Saralamba S, Effelterre T, Nokes DJ, White LJ
      
    </span>
    <span class="float-right">
      
<div class="share-box" aria-hidden="true">
  <ul class="share">
    <li>
      <a class="twitter"
         href="https://twitter.com/intent/tweet?text=Predicting%20the%20relative%20impacts%20of%20maternal%20and%20neonatal%20respiratory%20syncytial%20virus%20%28RSV%29%20vaccine%20target%20product%20profiles%3a%20A%20consensus%20modelling%20approach&amp;url=%2fpublication%2frsv_gsk_kilifi%2f"
         target="_blank" rel="noopener">
        <i class="fab fa-twitter"></i>
      </a>
    </li>
    <li>
      <a class="facebook"
         href="https://www.facebook.com/sharer.php?u=%2fpublication%2frsv_gsk_kilifi%2f"
         target="_blank" rel="noopener">
        <i class="fab fa-facebook-f"></i>
      </a>
    </li>
    <li>
      <a class="linkedin"
         href="https://www.linkedin.com/shareArticle?mini=true&amp;url=%2fpublication%2frsv_gsk_kilifi%2f&amp;title=Predicting%20the%20relative%20impacts%20of%20maternal%20and%20neonatal%20respiratory%20syncytial%20virus%20%28RSV%29%20vaccine%20target%20product%20profiles%3a%20A%20consensus%20modelling%20approach"
         target="_blank" rel="noopener">
        <i class="fab fa-linkedin-in"></i>
      </a>
    </li>
    <li>
      <a class="weibo"
         href="http://service.weibo.com/share/share.php?url=%2fpublication%2frsv_gsk_kilifi%2f&amp;title=Predicting%20the%20relative%20impacts%20of%20maternal%20and%20neonatal%20respiratory%20syncytial%20virus%20%28RSV%29%20vaccine%20target%20product%20profiles%3a%20A%20consensus%20modelling%20approach"
         target="_blank" rel="noopener">
        <i class="fab fa-weibo"></i>
      </a>
    </li>
    <li>
      <a class="email"
         href="mailto:?subject=Predicting%20the%20relative%20impacts%20of%20maternal%20and%20neonatal%20respiratory%20syncytial%20virus%20%28RSV%29%20vaccine%20target%20product%20profiles%3a%20A%20consensus%20modelling%20approach&amp;body=%2fpublication%2frsv_gsk_kilifi%2f">
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  </ul>
</div>


    </span>

    

    
    <h3>Abstract</h3>
    <p class="pub-abstract" itemprop="text">Background: Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding of the mechanism of natural immunity. We report consensus population level impact projections based on two mathematical models applied to a low income setting. Method: Two structurally distinct age-specific deterministic compartmental models reflecting uncertainty associated with the natural history of infection and the mechanism by which immunity is acquired and lost were constructed. A wide range of vaccine TPPs were explored including dosing regime and uptake, and effects in the vaccinated individual on infectiousness, susceptibility, duration of protection, disease severity and interaction with maternal antibodies and natural induced immunity. These were combined with a range of vaccine implementation strategies, targeting the highest priority age group and calibrated using hospitalization data from Kilifi County Hospital, Kenya. Findings: Both models were able to reproduce the data. The impact predicted by the two models was qualitatively similar across the range of TPPs, although one model consistently predicted higher impact than the other. For a proposed realistic range of scenarios of TPP combinations, the models predicted up to 70% reduction in hospitalizations in children under five years old. Vaccine designs which reduced the duration and infectiousness of infection were predicted to have higher impacts. The models were sensitive to the coverage and rate of loss of vaccine protection but not to the interaction between vaccine and maternal/naturally acquired immunity. Conclusion: The results suggest that vaccine properties leading to reduced virus circulation by lessening the duration and infectiousness of infection upon challenge are of major importance in population RSV disease control. These features should be a focus for vaccine development.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            <a href="/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">In <em>Vaccine</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Date</div>
          <div class="col-12 col-md-9" itemprop="datePublished">
            January, 2017
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-sm-none space-below"></div>

    <div class="row" style="padding-top: 10px">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading" style="line-height:34px;">Links</div>
          <div class="col-12 col-md-9">

            




<a class="btn btn-outline-primary my-1 mr-1" href="https://reader.elsevier.com/reader/sd/pii/S0264410X16310234?token=BDD4256EC6F633CAC530B1433066B8061201E2EBF2A918C1A5E7636E63FD0D7237FE50A460DC7B3D94780DDF1599B6B5" target="_blank" rel="noopener">
  PDF
</a>








  
  <a class="btn btn-outline-primary my-1 mr-1" href="/project/rsv/">
    Project
  </a>
  







<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1016/j.vaccine.2016.10.073" target="_blank" rel="noopener">
  DOI
</a>




          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-sm-none space-below"></div>

    <div class="space-below"></div>

    <div class="article-style"></div>

    


<div class="article-tags">
  
  <a class="badge badge-light" href="/tags/rsv-models/">RSV models</a>
  
</div>




  </div>
</div>



<div class="container">
  <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2021 Ben Githinga &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" id="back_to_top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

</div>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha512-+NqPlbbtM1QqiK8ZAo4Yrj2c4lNQoGv8P79DPtKzj++l5jnN39rHA/xsqn8zE9l0uSoxaCdrOgFs6yjyfbBxSg==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.3/imagesloaded.pkgd.min.js" integrity="sha512-umsR78NN0D23AzgoZ11K7raBD+R6hqKojyBZs1w8WvYlsI+QuKRGBx3LFCwhatzBunCjDuJpDHwxD13sLMbpRA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha256-VsEqElsCHSGmnmHXGQzvoWjWwoznFSZc6hs7ARLRacQ=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
        
      

      
      
    

    <script src="/js/hugo-academic.js"></script>
    

    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.js" integrity="sha512-lInM/apFSqyy1o6s89K4iQUKg6ppXEgsVxT35HbzUupEVRh2Eu9Wdl4tHj7dZO0s1uvplcYGmt3498TtHq+log==" crossorigin="anonymous"></script>
    

    
    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    <script>
      const search_index_filename = "/index.json";
      const i18n = {
        'placeholder': "Search...",
        'results': "Search Results",
        'no_results': "No results found"
      };
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    <script src="/js/search.js"></script>
    

    
    

  </body>
</html>

